Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer.
about
Recent advances in lymphatic targeted drug delivery system for tumor metastasisLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Efficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma.Doxorubicin-loaded silk films: drug-silk interactions and in vivo performance in human orthotopic breast cancer.Synthesis and characterization of a multi-arm poly(acrylic acid) star polymer for application in sustained delivery of cisplatin and a nitric oxide prodrug.Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma.Lymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic characterIn vitro and in vivo anti-cancer effects of targeting and photothermal sensitive solid lipid nanoparticles.A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancerCellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugatesMulti-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma.Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomasImpact of molecular weight on lymphatic drainage of a biopolymer-based imaging agentSubcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo.Current and future lymphatic imaging modalities for tumor stagingHyaluronic acid conjugates as vectors for the active targeting of drugs, genes and nanocomposites in cancer treatment.Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment.Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.Novel injectable thermosensitive hydrogels for delivering hyaluronic acid-doxorubicin nanocomplexes to locally treat tumors.Cytotoxicity of ICD-85 NPs on Human Cervical Carcinoma HeLa Cells through Caspase-8 Mediated Pathway.Tailored doxorubicin-hyaluronan conjugate as a potent anticancer glyco-drug: an alternative to prodrug approach.Smart multifunctional hollow microspheres for the quick release of drugs in intracellular lysosomal compartments.Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative.Tumor-Triggered Controlled Drug Release from Electrospun Fibers Using Inorganic Caps for Inhibiting Cancer Relapse.Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative.Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment.Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron.Polysaccharides for the Delivery of Antitumor Drugs.A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy.A H(+)-triggered bubble-generating nanosystem for killing cancer cells.Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work?Layer-by-layer microcapsules for pH-controlled delivery of small moleculesHydration forces as a tool for the optimization of core–shell nanoparticle vectors for cancer gene therapy
P2860
Q27005580-0685BDC1-9415-4487-AC83-B683A7BBA459Q30366990-16C7C48E-7B50-4B39-92FC-1F49B4F2763AQ30420306-605ACCA2-56FF-438B-8464-C8AEBB2D370BQ30525060-F634A8C6-ECE9-4FEA-9E96-55008C2DD62AQ31019887-06101F3E-428B-4FE7-B8FB-98FB02F064C7Q34377387-59F4597A-B933-4ADA-8BE2-5C90C842D12EQ34995612-75C9CAA9-769C-4322-B5CD-AB1C661D9A37Q35194733-EF81C1D9-3408-4E50-A01F-325CA2B78377Q36181844-9567BFEE-2C96-471C-81F4-048DA84BE5FAQ36204729-6435A66E-564D-4069-A14D-D599E8BB54A8Q36609101-99FE1042-1453-44B2-9AD8-D4513FD74DE7Q37186800-0037B735-CF5E-41F0-A935-02F8B88C671FQ37327825-5BD3C42F-0F4B-4EC6-9927-FDD411F707BCQ37543923-935076E0-EF9E-4664-8086-FB34D98C64A0Q37686649-1F1BC7B0-0451-4259-B675-2B80DCF7EDE0Q38197045-E13F3E8A-BA97-4F23-A029-B4198EEFACF9Q38665199-BCC10E32-7F1B-4F78-8E9A-52CF64F41D92Q38928173-4C0651FD-780B-4184-B260-034E46B829CCQ38931909-BEF55703-246E-4732-BB13-B0B1DB6A2B01Q39061493-7F01F457-EA80-4D6F-8389-8E7383F1E92EQ39077970-BBB47C60-D69B-4E31-AE2B-51EDE9AE1E21Q39507570-82A7A467-4476-4E1F-8883-43171F0D5C59Q42366841-DBBE6D1B-FC2F-4BF9-B46E-2C3BC6C0E84BQ43782567-2B5C5048-7AF6-4B62-A566-AD5CABB32132Q46373476-61B3D9FE-ACAB-4037-B5B7-07F8EC123DCCQ47726614-FAACF8F6-E956-4B15-AE58-E8064F8E74CEQ47959540-BCE4CD50-65E9-45E3-B5F8-A61425923213Q50347968-85627C9F-FB72-4A14-890B-61D3CEDD71C7Q50933336-3405A211-F932-490E-8038-8BD836803611Q51217340-3DC27AF6-0B9C-47AA-8A0A-32B5E735E666Q52676917-9FF043E4-FCAA-4584-8003-B16C214661B8Q57353636-162352BC-16A9-412F-AA92-E11ED05F3342Q57610433-2EAE37D8-B0B6-42B8-9A64-C3B597AFB645
P2860
Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Localized doxorubicin chemothe ...... grafts of human breast cancer.
@ast
Localized doxorubicin chemothe ...... grafts of human breast cancer.
@en
Localized doxorubicin chemothe ...... grafts of human breast cancer.
@nl
type
label
Localized doxorubicin chemothe ...... grafts of human breast cancer.
@ast
Localized doxorubicin chemothe ...... grafts of human breast cancer.
@en
Localized doxorubicin chemothe ...... grafts of human breast cancer.
@nl
prefLabel
Localized doxorubicin chemothe ...... grafts of human breast cancer.
@ast
Localized doxorubicin chemothe ...... grafts of human breast cancer.
@en
Localized doxorubicin chemothe ...... grafts of human breast cancer.
@nl
P2093
P2860
P921
P1476
Localized doxorubicin chemothe ...... grafts of human breast cancer.
@en
P2093
Hassam-Mustafa Diab
M Laird Forrest
Mark S Cohen
Neal M Davies
Sharadvi Thati
Shuang Cai
Taryn R Bagby
P2860
P304
P356
10.1016/J.JCONREL.2010.04.006
P407
P577
2010-04-18T00:00:00Z